ArticleResearch involvement and engagement2026
Cancer early detection research priorities in some underrepresented communities: a commentary of the learnings from a community priority setting project.
Article in Research involvement and engagement, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
background and approachPriority setting partnerships for health and social care, which aim to unite patient, professional and other stakeholder priorities for research don't always accurately reflect the views of underrepresented communities. Few have utilised community engagement methods. We expanded on an existing James Lind Alliance Priority Setting Partnership that asked patient, public and professional stakeholders what their top 10 research priorities were in cancer early detection. We worked with community partners to design and deliver an accessible and equitable community-based priority setting project that sought to understand the cancer early detection research priorities amongst underrepresented communities in Greater Manchester. This article reflects on and shares recommendations for future PSPs where community-led participatory methodologies are being considered. Participatory research priority setting activities were undertaken in four community sessions. Community-led activities with four partner community organisations were delivered across separate community ranking workshops involving 39 community members (92% Black, Asian and other ethnicities) and one action-planning workshop with 20 stakeholders, which brought community members, researchers, and community engagement practitioners together. Engagement methods were co-designed with community partners following recommendations from a power-sharing toolkit. IMPACT AND LEARNINGS: This community PSP project developed a revised top 10 priority list for cancer early detection research along with new research ideas. An inclusive research action plan was co-developed to address key themes from across the workshops. The project empowered community members who had never been involved in health research before to contribute to research developments, to learn about health research, and become engaged within local community centres. Future projects considering the use of community engagement and co-production methods should ensure activities are co-developed with the relevant community-partner stakeholders and that there is enough opportunity to develop reciprocal relationships between researchers, organisations and members of the community.
conclusionsCommunity engagement approaches to priority setting are valuable methods for engaging with underrepresented communities. Reciprocity and community-benefit should be at the forefront of these projects. We suggest a method for how future partnerships might choose to co-deliver community engaged priority setting.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.